Vitamin C in Disease Prevention and Cure: An Overview

Abstract

The recognition of vitamin C is associated with a history of an unrelenting search for the cause of the ancient haemorrhagic disease scurvy. Isolated in 1928, vitamin C is essential for the development and maintenance of connective tissues. It plays an important role in bone formation, wound healing and the maintenance of healthy gums. Vitamin C plays an important role in a number of metabolic functions including the activation of the B vitamin, folic acid, the conversion of cholesterol to bile acids and the conversion of the amino acid, tryptophan, to the neurotransmitter, serotonin. It is an antioxidant that protects body from free radical damage. It is used as therapeutic agent in many diseases and disorders. Vitamin C protects the immune system, reduces the severity of allergic reactions and helps to fight off infections. However the significance and beneficial effect of vitamin C in respect to human disease such as cancer, atherosclerosis, diabetes, neurodegenerative disease and metal toxicity however remains equivocal. Thus further continuous uninterrupted efforts may open new vistas to understand its significance in disease management.

This is a preview of subscription content, access via your institution.

References

  1. 1.

    Haworth WN, Hirst EL. Synthesis of ascorbic acid. J Soc Chem Ind (Lond). 1933;52:645–7.

    Google Scholar 

  2. 2.

    Nishikimi M, Fukuyama R, Minoshima S, Shimizu N, Yagi K. Cloning and chromosomal mapping of the human nonfunctional gene for l-gulono-gamma-lactone oxidase, the enzyme for l-ascorbic acid biosynthesis missing in man. J Biol Chem. 1994;269:13685–8.

    PubMed  CAS  Google Scholar 

  3. 3.

    Dunitz JD. Linus Carl Pauling. 28 February 1901–19 August 1994. Biographical Memoirs of Fellows of the Royal Society. 1996;42:316–8.

  4. 4.

    Stevenson NR, Brush MK. Existence and characteristic of Na+ dependent active transport of ascorbic acid in guinea pigs. Am J Clin Nutr. 1969;22:318.

    PubMed  CAS  Google Scholar 

  5. 5.

    Malo C, Wilson JX. Glucose modulates vitamin C transport in adult human small intestinal brush border membrane vesicles. J Nutr. 2000;130:63–9.

    PubMed  CAS  Google Scholar 

  6. 6.

    Takanga H, Mackenzie B, Hediger MA. Sodium dependent ascorbic acid transporter family SLC23. Pflugers Arch. 2004;447:677–82.

    Google Scholar 

  7. 7.

    Stewart JS, Booth CC. Ascorbic acid absorption in malabsorption. Acta Gastroenterol Belg. 1964;27:567–8.

    PubMed  CAS  Google Scholar 

  8. 8.

    Ralli EP, Friedman GJ, Rubin SH. The mechanism of the excretion of vitamin C by the human kidney. J Clin Invest. 1938;17:765–70.

    PubMed  CAS  Google Scholar 

  9. 9.

    Nelson EW, Lane H, Fabri PJ, Scott B. Demonstration of saturation kinetics in the intestinal absorption of vitamin C in man and the guinea pig. J Clin Pharmacol. 1978;18:325–35.

    PubMed  Google Scholar 

  10. 10.

    MacDonald L, Thumser AE, Sharp P. Decreased expression of the vitamin C transporter SVCT1 by ascorbic acid in a human intestinal epithelial cell line. Br J Nutr. 2002;87(20):97–100.

    PubMed  CAS  Google Scholar 

  11. 11.

    Wilson JX. Regulation of vitamin C transport. Ann Rev Nutr. 2005;25:105–25.

    CAS  Google Scholar 

  12. 12.

    Padayatty SJ, Sun H, Wang YH, Riordan HD, Hewitt SM, Katz A, et al. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med. 2004;140:533–7.

    PubMed  CAS  Google Scholar 

  13. 13.

    Levine M, Conry-Cantilena C, Wang Y, Welch RW, Washko PW, Dhariwal KR, et al. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci USA. 1996;93:3704–9.

    PubMed  CAS  Google Scholar 

  14. 14.

    Dixon SJ, Wilson JX. Adaptive regulation of ascorbate transport in osteoblastic cells. J Bone Miner Res. 1992;7:675–81.

    PubMed  CAS  Google Scholar 

  15. 15.

    Li Y, Schellhorn Herb E. New developments and novel therapeutic perspectives for vitamin C. J Nutr. 2007;137:2171–84.

    PubMed  CAS  Google Scholar 

  16. 16.

    Kallner AB, Hartmann D, Horning DH. Steady state turnover and body pool of ascorbic acid in man. Am J Clin Nutr. 1979;32:530–9.

    PubMed  CAS  Google Scholar 

  17. 17.

    Anderson D, Phillips BJ, Yu T, Edwards AJ, Ayesh R, Butterworth KR. The effect of vitamin C supplementation on biomarkers of oxygen radical generated damage in human volunteers with low or high cholesterol levels. Environ Mol Mutagen. 1997;30:161–74.

    PubMed  CAS  Google Scholar 

  18. 18.

    Johnson CS. Biomarkers for establishing a tolerable upper intake level for vitamin C. Nutr Rev. 1999;57:71–7.

    Google Scholar 

  19. 19.

    Naidu AK, Vitamin C. In human health and disease is still a mystery? An overview. Nutr J. 2003;2:7.

    PubMed  Google Scholar 

  20. 20.

    Levin M. New concepts in the biology and biochemistry of ascorbic acid. New Engl J Med. 1986;31:892–902.

    Google Scholar 

  21. 21.

    May JM, Zhi-chao Q. Transport and intracellular accumulation of vitamin C in endothelial cells: relevance to collagen synthesis. Arch Biochem Biophys. 2005;434:178–86.

    PubMed  CAS  Google Scholar 

  22. 22.

    Maehata Y, Takamizawa S, Ozawa S, Izukuri K, Kato Y, Sato S, et al. Type III collagen is essential for growth acceleration of human osteoblastic cells by ascorbic acid 2-phosphate, a long-acting vitamin C derivative. Matrix Biol. 2007;26(5):371–81.

    PubMed  CAS  Google Scholar 

  23. 23.

    Kishimoto Y, Saito N, Kurita K, Shimokado K, Maruyama N, Ishigami A. Ascorbic acid enhances the expression of type 1 and type 4 collagen and SVCT2 in cultured human skin fibroblasts. Biochem Biophys Res Commun. 2013;30(2):579–84.

    Google Scholar 

  24. 24.

    Hulse JD, Ellis SR, Henderson LM. Carnitine biosynthesis-beta hydroxylation of trimethyllysine by an α-ketoglutarate dependent mitochondrial dioxygenase. J Biol Chem. 1978;253:1654–9.

    PubMed  CAS  Google Scholar 

  25. 25.

    Rebouche CJ. Ascorbic acid and carnitine biosynthesis. Am J Clin Nutr. 1991;54(6):1147S–52S.

    PubMed  CAS  Google Scholar 

  26. 26.

    Cameron E, Pauling L. Ascorbic acid and the glycosaminoglycans. Oncology. 1973;27:181–92.

    PubMed  CAS  Google Scholar 

  27. 27.

    Anon. Ascorbic acid and catabolism of cholesterol. Nutr Rev 1973;31:154.

  28. 28.

    Sharma P, Pramod J, Kothari LK, Ranka R, Sharma S. Hyperlipidemia in guinea pigs induced by chronic vitamin C deficiency. IJCB. 1989;4:62–4.

    CAS  Google Scholar 

  29. 29.

    Sharma P, Pramod J, Sharma PK, Sapra M, Kothari LK. Effect of vitamin C deficiency and excess on the liver: a histopathological and biochemical study in guinea pigs fed normal or high cholesterol diet. Ind J Pathol Microbiol. 1990;33(4):307–13.

    CAS  Google Scholar 

  30. 30.

    Ginter E, Bobek P, Jurcovicova M. Role of ascorbic acid in lipid metabolism. In: Seith PA, Toblert BM, editors. Ascorbic acid, chemistry, metabolism and uses. Washington DC: American Chemical Society; 1982. p. 381–93.

    Google Scholar 

  31. 31.

    Gustafsson U, Wang FH, Axelson M, Kallner A, Sahlin S, Einarsson K. The effect of vitamin C in high doses on plasma and biliary lipid composition in patients with cholesterol gallstones: prolongation of the nucleation time. Eur J Clin Invest. 1997;27(5):387–91.

    PubMed  CAS  Google Scholar 

  32. 32.

    Pauling L. Vitamin C and common cold. San Francisco: Freeman; 1970.

    Google Scholar 

  33. 33.

    Elwood PC, Lee HP, St Leger AS, Baird M, Howard AN. A randomized controlled trial of vitamin C in the prevention and amelioration of the common cold. Br J Prev Soc Med. 1976;30(3):193–6.

    PubMed  CAS  Google Scholar 

  34. 34.

    Hemilä H, Chalker E. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev. 2013;1:CD000980. doi:10.1002/14651858.CD000980.

  35. 35.

    Douglas RM, Chalker EB, Treacy B. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev. 2000;2:CD000980.

    PubMed  Google Scholar 

  36. 36.

    Campbell JD, Cole M, Bunditrutavorn B, Vell AT. Ascorbic acid is a potent inhibitor of various forms of T cell apoptosis. Cell Immunol. 1999;194:1–5.

    PubMed  CAS  Google Scholar 

  37. 37.

    Wintergerst ES, Maggini S, Hornig DH. Immune-enhancing role of vitamin C and zinc and effect on clinical conditions. Ann Nutr Metab. 2006;50(2):85–94.

    PubMed  CAS  Google Scholar 

  38. 38.

    Bourne GH. The effect of vitamin C on healing wounds. Proc Nutr Soc. 1946;4:204.

    PubMed  CAS  Google Scholar 

  39. 39.

    Hellman L, Burns JJ. Metabolism of l-ascorbic acid-1-C14 in man. J Biol Chem. 1958;230:923–30.

    PubMed  CAS  Google Scholar 

  40. 40.

    Jagetia GC, Rajanikant GK, Mallikarjun Rao KVN. Ascorbic acid increases healing of excision wounds of mice whole body exposed to different doses of γ-radiation. Burns. 2007;33(4):484–94.

    PubMed  Google Scholar 

  41. 41.

    Hallberg L. Bioavailability of dietary iron in man. Annu Rev Nutr. 1981;1:123–7.

    PubMed  CAS  Google Scholar 

  42. 42.

    Bendich A, Cohen M. Ascorbic acid safety: analysis factors affecting iron absorption. Toxicol Lett. 1990;51:189–90.

    PubMed  CAS  Google Scholar 

  43. 43.

    Zhang Y, Zhao D, Xu J, Xu C, Dong C, Liu Q, et al. Effects of dietary factors on the pharmacokinetics of (58)Fe-labeled hemin after oral administration in normal rats and the iron-deficient rats. Biol Trace Elem Res. 2013;153(1–3):243–50.

    PubMed  CAS  Google Scholar 

  44. 44.

    Gowri S, Patel K, Prakash J, Srinivasan K. Influence of amla fruits (Emblica officinalis) on the bio-availability of iron from staple cereals and pulses. Nutr Res. 2001;21(12):1483–92.

    CAS  Google Scholar 

  45. 45.

    Chiu PF, Ko SY, Chang CC. Vitamin C affects the expression of hepcidin and erythropoietin receptor in HepG2 cells. J Ren Nutr. 2012;22(3):373–6.

    PubMed  CAS  Google Scholar 

  46. 46.

    Darius Lane JR, Chikhani S, Richardson V, Richardson Des R. Transferrin iron uptake is stimulated by ascorbate via an intracellular reductive mechanism. Biochim Biophys Acta. 2013;1833(6):1527–41.

    PubMed  Google Scholar 

  47. 47.

    Samuni A, Aronovitch J, Godinger D, Chevion M, Czapski G. On the cytotoxicity of vitamin C and metal ions: a site specific Fenton mechanism. Eur J Biochem. 1983;137:119–20.

    PubMed  CAS  Google Scholar 

  48. 48.

    Minetti M, Forte T, Soriani M, Quaresima V, Menditto A, Ferrari M. Iron Induced ascorbate oxidation in plasma as monitored by ascorbate free radical formation: no spin trapping evidence for the hydroxyl radical in iron-over loaded plasmas. Biochem J. 1992;282:459–65.

    PubMed  CAS  Google Scholar 

  49. 49.

    Berger TM, Mumby S, Gutteridge JMC. Ferrous ion detected in iron-overloaded cord blood plasma from preterm and term babies: implication for oxidation stress. Free Radic Res. 1995;22:555–9.

    PubMed  CAS  Google Scholar 

  50. 50.

    Halliwell B. Vitamin C: antioxidant or pro-oxidant in vivo ? Free Radic Res. 1996;25:439–54.

    PubMed  CAS  Google Scholar 

  51. 51.

    Herbert V, Shaw S, Jayatileke E. Vitamin C driven free radicals generation from iron. J Nutr. 1996;126:1213–20.

    Google Scholar 

  52. 52.

    Proteggente AR, Rehman A, Halliwell B, Rice-Evans CA. Potential problems of ascorbic acid and iron supplementation: pro-oxidant effect in vivo? Biochem Biophys Res Commun. 2000;277:535–54053.

    PubMed  CAS  Google Scholar 

  53. 53.

    Mathur V, Murdia A, Hakim AA, Suhalka ML, Shaktawat GS, Kothari LK. Male infertility and the present status of its management by drugs. J Postgrad Med. 1979;25:90–6.

    PubMed  CAS  Google Scholar 

  54. 54.

    Huggins C, Scott WW, Heinen JH. Chemical composition of human serum and of the secretion of prostate and seminal vesicles. Am J Physiol. 1942;136:467–73.

    CAS  Google Scholar 

  55. 55.

    Mann T. Biochemistry of semen and of the male reproductive tract. London: Methnen and Co. Ltd.; 1954. p. 20.

    Google Scholar 

  56. 56.

    Chinoy NJ. Ascorbic acid turn over in animal and human tissue. J Anim Morphol Physiol. 1978; (Silver Jubilee Volume):69–85.

  57. 57.

    Chinoy MR, Sharma JD, Sanjeevan AG, Chinoy NJ. Structural changes in male reproductive organs and spermatozoa of scorbutic guinea-pigs. Proc Ind Natl Sci Acad. 1983;B49:628–35.

    Google Scholar 

  58. 58.

    Gomes S, Odour OD, Bharaj B, Verjee ZH. Gonadal and plasma testosterone and cholesterol in scorbutic guinea-pigs. Int J Vit Nutr Res. 1977;47:75–80.

    Google Scholar 

  59. 59.

    Paul PK, Datta-Gupta PN. Beneficial or harmful effects of a large dose of vitamin C on the reproductive organs of the male rat depending upon the level of food intake. Ind J Exp Biol. 1978;16:18–21.

    CAS  Google Scholar 

  60. 60.

    Sapra M, Sharma P, Kothari LK. Effect of vitamin C deficiency on testicular structure in the guinea pig. J Postgrad Med. 1987;33:69–73.

    PubMed  CAS  Google Scholar 

  61. 61.

    Agarwal A. Role of antioxidants in treatment of male infertility. Reprod Biomed Online. 2004;8:616–27.

    PubMed  CAS  Google Scholar 

  62. 62.

    Abasalt H, Colagar Eisa T, Marzony. Ascorbic acid in human seminal plasma: determination and its relationship to sperm quality. J Clin Biochem Nutr. 2009;45(2):144–9.

    Google Scholar 

  63. 63.

    Saleh RA, Agarwal A, Nada EA, Tonsy MH, Sharma RK, Meyer A, et al. Negative effects of increased sperm DNA damage in relation to seminal oxidative stress in men with idiopathic and male factor infertility. Fertil Steril. 2003;79:1597.

    PubMed  Google Scholar 

  64. 64.

    Shi YC, Sun HM, Shang XJ, Zhu PY, Huang YF. Total antioxidant capacity of seminal plasma in fertile and infertile men. Zhonghua Nan Ke Xue. 2005;11:915–7.

    PubMed  Google Scholar 

  65. 65.

    Shi YC, Shang XJ, Wang XL, Huang YF. Correlation of total antioxidant capacity in seminal plasma with sperm motility of infertile men. Zhonghua Nan Ke Xue. 2006;12:703–5.

    PubMed  CAS  Google Scholar 

  66. 66.

    Agarwal A, Ikemoto I, Loughlin KR. Relationship of sperm parameters to levels of reactive oxygen species in semen specimens. J Urol. 1994;152:107–10.

    PubMed  CAS  Google Scholar 

  67. 67.

    Shukla KK, Mahdi AA, Ahmad MK, Jaiswar SP, Shankwar SN, Tiwari SC. Mucuna pruriens reduces stress and improves the quality of semen in infertile men. Evid Based Complement Alternat Med. 2010;7(1):137–44.

    PubMed  Google Scholar 

  68. 68.

    Hampl R, Drábková P, Kanďár R, Stěpán J. Impact of oxidative stress on male infertility. Ceska Gynekol. 2012;77(3):241–5.

    PubMed  CAS  Google Scholar 

  69. 69.

    Doshi SB, Khullar K, Sharma RK, Agarwal A. Role of reactive nitrogen species in male infertility. Reprod Biol Endocrinol. 2012;15(10):109.

    Google Scholar 

  70. 70.

    Patriarca M, Menditto A, Morisi G. Determination of ascorbic acid in blood or serum and in seminal plasma using a simplified sample preparation and high performance liquid chromatography coupled with UV detection. J Liq Chromatogr. 1991;14:297–312.

    CAS  Google Scholar 

  71. 71.

    Aitken RJ, Baker MA. Oxidative stress, sperm survival and fertility control. Mol Cell Endocrinol. 2006;250:66–9.

    PubMed  CAS  Google Scholar 

  72. 72.

    Donnelly ET, McClure N, Lewis SE. Glutathione and hypotaurine in vitro: effects on human sperm motility, DNA integrity and production of reactive oxygen species. Mutagenesis. 2000;15:61–8.

    PubMed  CAS  Google Scholar 

  73. 73.

    Kodama H, Yamaguchi R, Fukuda J, Kasi H, Tanaka K. Increased oxidative deoxyribonucleic acid damage in spermatozoa of infertile male patients. Fertil Steril. 1997;68:519–24.

    PubMed  CAS  Google Scholar 

  74. 74.

    Donnelly E, McClure N, Lewis SEM. The effect of ascorbate and alpha-tocopherol supplementation in vitro on DNA integrity and hydrogen peroxide induced DNA damage in human spermatozoa. Mutagenesis. 1999;14:505–12.

    PubMed  CAS  Google Scholar 

  75. 75.

    Jelodar G, Nazifi S, Akbari A. The prophylactic effect of vitamin C on induced oxidative stress in rat testis following exposure to 900 MHz radio frequency wave generated by a BTS antenna model. Electromagn Biol Med. 2013. doi:10.3109/15368378.2012.735208.

  76. 76.

    Verma A, Kanwar KC. Human sperm motility and lipid peroxidation in different ascorbic acid concentrations: an invitro analysis. Andrologia. 1998;30:325–9.

    PubMed  CAS  Google Scholar 

  77. 77.

    Henmi H, Endo T, Kitaiima Y, et al. Effects of ascorbic acid supplementation on serum progesterone levels in patients with a luteal phase defect. Fertil Steril. 2002;80:459–61.

    Google Scholar 

  78. 78.

    Myasnikova IA. Effect of ascorbic acid, nicotinic acid and thiamine on cholestolemia. Voenno Morski Med Akad Leningrad. 1947;8:140.

    Google Scholar 

  79. 79.

    Ginter E, Zolch Z. Raised ascorbic acid consumption in cholesterol fed guinea pigs. Int J Vit Nutr Res. 1972;42:72.

    CAS  Google Scholar 

  80. 80.

    Krumdieck C, Butterworth CE. Ascorbate–cholesterol–lecithin interactions factors of potential importance in pathogenesis of atherosclerosis. Am J Clin Nutr. 1974;27:866.

    PubMed  CAS  Google Scholar 

  81. 81.

    Banerjee S, Gosh PK. Metabolism of acetate in scorbutic guinea pigs. Am J Physiol. 1960;199:1064.

    PubMed  CAS  Google Scholar 

  82. 82.

    Das S, Snehlata, Srivastava LK. Effect of ascorbic acid on lipid profile and per-oxidation in hypercholestrolemic rabbits. Nutr Res. 1997;17(2):231–41.

    CAS  Google Scholar 

  83. 83.

    Ginter E, Babla J, Cerven J. The effect of chronic hypovitaminosis C on the metabolism of cholesterol and atherogenesis in guinea pigs. J Atheroscler Res. 1969;10:341.

    PubMed  CAS  Google Scholar 

  84. 84.

    Frikke-Schmidt H, Lykkesfeld J. Role of marginal vitamin C deficiency in atherogenesis: in vivo models and clinical studies. 2009. doi:10.1111/j.1742-7843.2009.00420.

  85. 85.

    Frikke-Schmidt H, Tveden-Nyborg P, Muusfeldt Birck M, Lykkesfeldt J. High dietary fat and cholesterol exacerbates chronic vitamin C deficiency in guinea pigs. Br J Nutr. 2011;105:54–61.

    PubMed  CAS  Google Scholar 

  86. 86.

    Sharma P, Pramod J, Sharma PK, Chaturvedi SK, Kothari LK. Effect of vitamin C administration on serum and aortic lipid profile of guinea pigs. IJMR. 1988;87:28.

    Google Scholar 

  87. 87.

    Kothari LK, Sharma P. Aggravation of cholesterol induced hyperlipidemia by chronic vitamin C deficiency: experimental study in guinea pigs. Acta Biol Hung. 1988;39(1):4.

    Google Scholar 

  88. 88.

    Vaney N, Sharma P, Pramod J, Varandami J, Kothari LK. Leucocyte ascorbic acid and blood lipids in normocholesterolemic men receiving different amounts of vitamin C. Vitaminologia. 1988;4:47–8.

    Google Scholar 

  89. 89.

    Gaur GS, Dixit AK. Comparative study of vitamin C on serum lipid profile in healthy male and female human subjects. J Sci Res. 2012;4(3):775–81.

    CAS  Google Scholar 

  90. 90.

    Marc P, McRae. Vitamin C supplementation lowers serum low-density lipoprotein cholesterol and triglycerides: a meta-analysis of 13 randomized controlled trials. JCM. 2008;7(2):548–81.

    Google Scholar 

  91. 91.

    Itoh R, Yamada K, Oka J, Echizen H, Suyama Y, Murakami K. Serum ascorbic acid and HDL cholesterol in a healthy elderly Japanese population. Int J Vit Nutr Res. 1990;60(4):360–5.

    CAS  Google Scholar 

  92. 92.

    Jacques PF. Effects of vitamin C on high-density lipoprotein cholesterol and blood pressure. J Am Coll Nutr. 1992;11(2):139–44.

    PubMed  CAS  Google Scholar 

  93. 93.

    Jacques PF, Sulsky SI, Perrone GA, Schaefer EJ. Ascorbic acid and plasma lipids. Epidemiology. 1994;5(1):19–26.

    PubMed  CAS  Google Scholar 

  94. 94.

    Jacques PF, Sulsky SI, Perrone GE, Jenner J, Schaefer EJ. Effect of vitamin C supplementation on lipoprotein cholesterol, apolipoprotein, and triglyceride concentrations. Ann Epidemiol. 1995;5(1):52–9.

    PubMed  CAS  Google Scholar 

  95. 95.

    Okamoto K. The relationship between dietary ascorbic acid intake and serum lipid concentration in the aged. Nihon Ronen Igakkai Zasshi. 1992;29(12):908–11.

    PubMed  CAS  Google Scholar 

  96. 96.

    Simon JA, Hudes ES. Relation of serum ascorbic acid to serum lipids and lipoproteins in US adults. J Am Coll Nutr. 1998;17(3):250–5.

    PubMed  CAS  Google Scholar 

  97. 97.

    Manson JE, Stampfer MJ, Willett WC, et al. A prospective study of vitamin C and incidence of coronary heart disease in women. Circulation. 1982;85:865–75.

    Google Scholar 

  98. 98.

    Knekt P, Reunanen A, Jarvinen R, Seppanen R, Heliovaara M, Aromaa A. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol. 1994;139:1180–9.

    PubMed  CAS  Google Scholar 

  99. 99.

    Rimm EB, Stampfer MJ, Ascherio A, Giovanno E, Colditz GA, Willettt WC. Vitamin E consumption and risk of coronary heart disease in men. N Engl J Med. 1993;328:1450–6.

    PubMed  CAS  Google Scholar 

  100. 100.

    Enstrom JE, Kanim LE, Klein MA. Vitamin C intake and mortality among a sample of the United States population. Epidemiology. 1992;3:194–202.

    PubMed  CAS  Google Scholar 

  101. 101.

    Pramod J, Sharma P, Kothari LK. Effect of age and sex on serum and leucocyte ascorbic acid levels in normal human subjects. Vitaminologia. 1986;2:93–100.

    Google Scholar 

  102. 102.

    Kothari LK, Pramod J, Sharma P, Chaturvedi SK. Influence of age and vitamin C status on serum cholesterol. IJE. 1988;17(4):929–30.

    CAS  Google Scholar 

  103. 103.

    Gale CR, Martyn CN, Winter PD, Cooper C. Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people. Br Med J. 1995;310:1563–6.

    CAS  Google Scholar 

  104. 104.

    Ness A, Egger M, Davey-Smith G. Role of antioxidant vitamins in prevention of cardiovascular disease. Br Med J. 1999;319:577–9.

    CAS  Google Scholar 

  105. 105.

    Steinbrecher UP, Zhang H, Lougheed M. Role of oxidative modified LDL in atherosclerosis. Free Radic Biol Med. 1990;9:155–68.

    PubMed  CAS  Google Scholar 

  106. 106.

    Frei B. Vitamin C as an antiatherogen: mechanism of action. In: Packer L, Fuchs J, editors. Vitamin C in health and disease. New York: Marcel and Dekker Inc; 1997. p. 163–82.

    Google Scholar 

  107. 107.

    Berger TM, Polidori MC, Dabhag A, Evans PJ, Halliwell B, Marrow JD, et al. Antioxidant activity of vitamin C in iron over loaded human plasma. J Biol Chem. 1992;272:15656–60.

    Google Scholar 

  108. 108.

    Dasgupta A, Zdunek T. In vitro lipid peroxidation of human serum catalyzed by copper ion: antioxidant rather than prooxidant role of ascorbate. Life Sci. 1992;50:2875–82.

    Google Scholar 

  109. 109.

    Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci USA. 1989;86:6377–81.

    PubMed  CAS  Google Scholar 

  110. 110.

    Martin A, Frei B. Both intracellular and extracellular vitamin C inhibit atherogenic modification of LDL by human vascular endothelial cells. Atheroscler Thromb Vasc Biol. 1997;17:1583–90.

    CAS  Google Scholar 

  111. 111.

    Das S, Snehlata DN, Srivastava LM. Role of ascorbic acid on in vitro oxidation of low-density lipoprotein derived from hypercholesterolemic patients. Clin Chim Acta. 2006;372(1-2):202–5.

    PubMed  CAS  Google Scholar 

  112. 112.

    Shariat SZAS, Mostafavi SA, Khakpour F. Antioxidant effects of vitamins C and E on the low-density lipoprotein oxidation mediated by myeloperoxidase. Iran Biomed J. 2013;17(1):22–8.

    CAS  Google Scholar 

  113. 113.

    Lehr HA, Frei B, Arfors KE. Vitamin C prevents cigarette smoke-induced leukocyte aggregation and adhesion to endothelium in vivo. Proc Natl Acad Sci USA. 1994;91:7688–92.

    PubMed  CAS  Google Scholar 

  114. 114.

    Lehr HA, Weyrich AS, Saetzler RK, Jurek A, Arfors KE, Zimmerman GA, et al. Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking. J Clin Invest. 1997;99:2358–64.

    PubMed  CAS  Google Scholar 

  115. 115.

    Lehr HA, Frei B, Olofsson AM, Carew TE, Arfors KE. Protection from oxidized LDL induced leukocyte adhesion to microvascular and macrovascular endothelium in vivo by vitamin C but not by vitamin E. Circulation. 1995;91:1552–3.

    Google Scholar 

  116. 116.

    Kaneko T, Kaji K, Mastuo M. Protective effect of lipophilic derivatives of ascorbic acid on lipid peroxide-induced endothelial injury. Arch Biochem Biophys. 1993;304:176–80.

    PubMed  CAS  Google Scholar 

  117. 117.

    Sabharwal AK, May JM. Alpha-lipoic acid and ascorbate prevent LDL oxidation and oxidant stress in endothelial cells. Mol Cell Biochem. 2008;309:125–32.

    PubMed  CAS  Google Scholar 

  118. 118.

    Anderson D, Phillips BJ, Yu T, Edwards AJ, Ayesh R, Butterworth KR. The effect of vitamin C supplementation on biomarkers of oxygen radical generated damage in human volunteers with low or high cholesterol levels. Environ Mol Mutagen. 1997;30:161–74.

    PubMed  CAS  Google Scholar 

  119. 119.

    Fuller CJ, Grundy SM, Norkus EP, Jialal I. Effect ascorbate supplementation on low density lipoprotein oxidation in smokers. Atherosclerosis. 1996;119:139–50.

    PubMed  CAS  Google Scholar 

  120. 120.

    Nyyssonen K, Poulsen HE, Hayn M, Agerbo P, Porkkalo Sarataho E, Kaikkonen J, et al. Effect of supplementation of smoking men with plain or slow release ascorbic acid on lipoprotein oxidation. Eur J Clin Nutr. 1997;51:154–63.

    PubMed  CAS  Google Scholar 

  121. 121.

    Samman S, Brown AJ, Beltran C, Singh S. The effect of ascorbic acid on plasma lipids and oxidisability of LDL in male smokers. Eur J Clin Nutr. 1997;51:472–7.

    PubMed  CAS  Google Scholar 

  122. 122.

    Wen Y, Cooke T, Feely J. The effects of pharmacological supplementation with vitamin C on low density lipoprotein oxidation. Br J Clin Pharmacol. 1997;44:94–7.

    PubMed  CAS  Google Scholar 

  123. 123.

    Valkonen MM, Kuusi T. Vitamin C prevents the acute atherogenic effects of passive smoking. Free Radic Biol Med. 2000;28(3):3–428.

    Google Scholar 

  124. 124.

    Carr AC, Frei B. Does vitamin C act as pro-oxidant under physiological conditions? FASEB J. 1999;13:1007–24.

    Google Scholar 

  125. 125.

    May JM, Li L, Qu ZC. Oxidized LDL up-regulates the ascorbic acid transporter SVCT2 in endothelial cells. ZC Mol Cell Biochem. 2010;343(12):217–22.

    CAS  Google Scholar 

  126. 126.

    Kapsokefalou M, Miller DD. Iron loading and large doses of intravenous ascorbic acid promote lipid peroxidation in whole serum in guinea pigs. Br J Nutr. 2001;85:681–7.

    PubMed  CAS  Google Scholar 

  127. 127.

    Chen K, Suh J, Carr AC, Marrow JD, Zeind J, Frei B. Vitamin C suppresses lipid damage in vivo even in the presence of iron over-load. Am J Physiol Endocrinol Metab. 2000;279:E1212–406.

    Google Scholar 

  128. 128.

    Ginter E, Adama M. Characterization of the aortic collagens in guinea pigs with chronic vitamin C deficiency. Atherosclerosis. 1983;46(3):369–73.

    PubMed  CAS  Google Scholar 

  129. 129.

    Rath M. Eradicating heart disease. San Francisco: Health Now; 1993.

    Google Scholar 

  130. 130.

    Lehr HA. Protection from oxidized LDL induced leukocyte adhesion to microvascular and macrovascular endothelium in-vivo by vitamin C but not by vitamin E. Circulation. 1995;91:1525–32.

    PubMed  CAS  Google Scholar 

  131. 131.

    Weber C. Increased adhesiveness of isolated monocytes to endothelium is prevented by vitamin C intake in smokers. Circulation. 1996;93:1488–92.

    PubMed  CAS  Google Scholar 

  132. 132.

    Nakata Y, Maeda N. Vulnerable atherosclerotic plaque morphology in apolipoprotein E-deficient mice unable to make ascorbic acid. Circulation. 2002;105:1485–90.

    PubMed  CAS  Google Scholar 

  133. 133.

    Cameron E, Campbell A. The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer. Chem Biol Interact. 1974;9:285–315.

    PubMed  CAS  Google Scholar 

  134. 134.

    Cameron E, Pauling L. Supplemental ascorbate in the supportive treatment of cancer: prolongation of survival times in terminal human cancer. Proc Natl Acad Sci USA. 1976;73:3685–9.

    PubMed  CAS  Google Scholar 

  135. 135.

    Cameron E, Pauling L. Supplemental ascorbate in the supportive treatment of cancer: re-evaluation of prolongation of survival times in terminal human cancer. Proc Natl Acad Sci USA. 1978;75:4538–42.

    PubMed  CAS  Google Scholar 

  136. 136.

    Murata A, Morishige F, Yamaguchi H. Prolongation of survival times of terminal cancer patients by administration of large doses of ascorbate. Int J Vit Nutr Res. 1982;2/23:103–13.

    Google Scholar 

  137. 137.

    Block G. Vitamin C and cancer prevention: the epidemiologic evidence. Am J Clin Nutr. 1991;53(1):270S–82S.

    PubMed  CAS  Google Scholar 

  138. 138.

    Block G. Epidemiologic evidence regarding vitamin C and cancer. Am J Clin Nutr. 1991;54(6):1310S.

    PubMed  CAS  Google Scholar 

  139. 139.

    Head KA. Ascorbic acid in the prevention and treatment of cancer. Altern Med Rev. 1998;3(3):174–86.

    PubMed  CAS  Google Scholar 

  140. 140.

    Block G, Patterson B, Subar A. Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr Cancer. 1992;18:1–29.

    PubMed  CAS  Google Scholar 

  141. 141.

    Steinmetz KA, Potter JD. Vegetables, fruit, and cancer prevention: a review. J Am Diet Assoc. 1996;96:1027–39.

    PubMed  CAS  Google Scholar 

  142. 142.

    Loria CM, Klag MJ, Caulfield LE, Whelton PK. Vitamin C status and mortality in US adults. Am J Clin Nutr. 2000;72:139–45.

    PubMed  CAS  Google Scholar 

  143. 143.

    Khaw KT, Bingham S, Welch A, Luben R, Wareham N, Oakes S, Day N. Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: a prospective population study: European prospective investigation into cancer and nutrition. Lancet. 2001;357:657–63.

    PubMed  CAS  Google Scholar 

  144. 144.

    Kushi LH, Fee RM, Sellers TA, Zheng W, Folsom AR. Intake of vitamins A, C, and E and postmenopausal breast cancer: The Iowa Women’s Health Study. Am J Epidemiol. 1996;144(2):165–74.

    PubMed  CAS  Google Scholar 

  145. 145.

    Padayatty SJ, Riordan HD, Hewitt SM, Katz A, Hoffer LJ, Levine M. Intravenously administered vitamin C as cancer therapy: three cases. CMAJ. 2006;174:937–42.

    PubMed  Google Scholar 

  146. 146.

    Kathleen A. Ascorbic acid in prevention and treatment of cancer. Altern Med Rev. 1988;3(3):174–86.

    Google Scholar 

  147. 147.

    Chen Q, Espey MG, Krishna MC, Mitchell JB, Corpe CP, Buettner GR, et al. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci USA. 2005;102:13604–9.

    PubMed  CAS  Google Scholar 

  148. 148.

    Cabanillas F. Vitamin C and cancer: what can we conclude—1, 609 patients and 33 years later? P R Health Sci J. 2010;29(3):215–7.

    PubMed  Google Scholar 

  149. 149.

    Cha J, Roomi MW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M. Ascorbate depletion increases growth and metastasis of melanoma cells in vitamin C deficient mice. Exp Oncol. 2011;33(4):226–30.

    PubMed  CAS  Google Scholar 

  150. 150.

    Cha J, Roomi MW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M. Ascorbate supplementation inhibits growth and metastasis of B16FO melanoma and 4T1 breast cancer cells in vitamin C-deficient mice. Int J Oncol. 2013;42(1):55–64.

    PubMed  CAS  Google Scholar 

  151. 151.

    Assouline S, Miller WH. High-dose vitamin C therapy: renewed hope or false promise? CMAJ. 2006;174:956–7.

    PubMed  Google Scholar 

  152. 152.

    Yeom CH, Jung GC, Song KJ. Changes of terminal cancer patients’ health-related quality of life after high dose vitamin C administration. J Korean Med Sci. 2007;22:7–11.

    PubMed  CAS  Google Scholar 

  153. 153.

    Wild SH, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53.

    PubMed  Google Scholar 

  154. 154.

    American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33:S62.

    Google Scholar 

  155. 155.

    Tesfaye S, Gill G. Chronic diabetic complications in Africa. Afr J Diabetes Med. 2011;19:4–8.

    Google Scholar 

  156. 156.

    Chintan AP, Nimish LP, Nayana B, Bhavna M, Mahendra G, Hardik T. Cardiovascular complication of diabetes mellitus. J Appl Pharm Sci. 2011;4:1–6.

    Google Scholar 

  157. 157.

    Vincintini Juliana MS, Valentini Juliana MS, Grotto Denise MS, Paniz C, Roehrs M, Brucker N, et al. Association among microalbuminuria and oxidative stress biomarkers in patients with type 2 diabetes. J Investig Med. 2011;59:649–54.

    Google Scholar 

  158. 158.

    Rosen P, Nawroth PP, King G, Moller W, Tritschler HJ, Packer L. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev. 2001;17:189–912.

    PubMed  CAS  Google Scholar 

  159. 159.

    Harding AH, Wareham NJ, Bingham SA, Khaw K, Luben R, Welch A, et al. Plasma vitamin C level, fruit and vegetable consumption, and the risk of new-onset type 2 diabetes mellitus: the European prospective investigation of cancer—Norfolk prospective study. Arch Intern Med. 2008;168(14):1493–9.

    PubMed  Google Scholar 

  160. 160.

    Montenen J, Knekt P, Jarvinen R, Reunanen A. Dietary antioxidants and risk of type 2 diabetes. Diabetes Care. 2004;27:362–6.

    Google Scholar 

  161. 161.

    Maxwell SR, Thomason H, Sandler D, Leguen C, Baxter MA, Thorpe GH, et al. Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus. Eur J Clin Invest. 1997;27(6):484–90.

    PubMed  CAS  Google Scholar 

  162. 162.

    Odum EP, Ejilemele AA, Wakwe VC. Antioxidant status of type 2 diabetic patients in Port Harcourt, Nigeria. Niger J Clin Pract. 2012;15(1):55–8.

    PubMed  CAS  Google Scholar 

  163. 163.

    Mazloom Z, Hejazi N, Dabbaghmanesh MH, Tabatabaei HR, Ahmadi A, Ansar H. Effect of vitamin C supplementation on postprandial oxidative stress and lipid profile in type 2 diabetic patients. Pak J Biol Sci. 2011;14(19):900–4.

    PubMed  CAS  Google Scholar 

  164. 164.

    Sharma P, Mishra S, Ajmera P, Mathur S. Oxidative stress in metabolic syndrome. Indian J Clin Biochem. 2005;20(1):145–9.

    PubMed  CAS  Google Scholar 

  165. 165.

    Özkaya D, Naziroğlu M, Armağan A, Demirel A, Köroglu BK, Çolakoğlu N, et al. Dietary vitamin C and E modulates oxidative stress induced-kidney and lens injury in diabetic aged male rats through modulating glucose homeostasis and antioxidant systems. Cell Biochem Funct. 2011;29(4):287–93.

    PubMed  Google Scholar 

  166. 166.

    Naziroğlu M, Butterworth PJ, Sonmez TT. Dietary vitamin C and E modulates antioxidant levels in blood, brain, liver, muscle, and testes in diabetic aged rats. Int J Vit Nutr Res. 2011;81(6):347–57.

    Google Scholar 

  167. 167.

    Sridulyakul P, Wongeak-in N, Patumraj S. Correlations between endothelial functions and ROS detection in diabetic microvascular wall: early and late ascorbic acid supplementation. Int J Vasc Med. 2012;2012:709695.

    PubMed  Google Scholar 

  168. 168.

    Hoffman RP, Dye AS, Bauer JA. Ascorbic acid blocks hyperglycaemic impairment of endothelial function in adolescents with type 1 diabetes. Pediatr Diabetes. 2012;13(8):607–10.

    PubMed  CAS  Google Scholar 

  169. 169.

    Prakash J, Hota J, Singh S, Sharma O. Clinical spectrum of chronic renal failure in the elderly: a hospital based study from eastern India. Int Urol Nephrol. 2006;38:821–7.

    PubMed  Google Scholar 

  170. 170.

    Qin QJ, Deng HC, Zhao TF, Cao WF, Liu DF, Lan LZ. Study on the effect and mechanism of ascorbic acid on renal podocytes in diabetes. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2008;24(1):112–5.

    PubMed  CAS  Google Scholar 

  171. 171.

    Lee EY, Lee MY, Hong SW, Chung CH, Hong SY. Blockade of oxidative stress by vitamin C ameliorates albuminuria and renal sclerosis in experimental diabetic rats. Yonsei Med J. 2007;48(5):847–55.

    PubMed  CAS  Google Scholar 

  172. 172.

    Kowluru RA, Tang J, Kern TS. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes. 2001;50:1938–42.

    PubMed  CAS  Google Scholar 

  173. 173.

    Mustata GT, Rosca M, Biemel KM, Reihl O, Smith MA, Viswanathan A. Paradoxical effects of green tea (Camellia sinensis) and antioxidant vitamins in diabetic rats: improved retinopathy and renal mitochondrial defects but deterioration of collagen matrix glycoxidation and cross-linking. Diabetes. 2005;4:517–26.

    Google Scholar 

  174. 174.

    Penn JS, Madan A, Caldwell RB, Bartoli M, Caldwell RW, Hartnett ME. Vascular endothelial growth factor in eye disease. Prog Retin Eye Res. 2008;27:331–71.

    PubMed  CAS  Google Scholar 

  175. 175.

    Cotter MA, Love A, Watt MJ, Cameron NE, Dines KC. Effects of natural free radical scavengers on peripheral nerve and neurovascular function in diabetic rats. Diabetologia. 1995;38(11):1285–94.

    PubMed  CAS  Google Scholar 

  176. 176.

    Ziegler D, Sohr CG, Nourooz-Zadeh J. Oxidative stress and antioxidant defense in relation to the severity of diabetic polyneuropathy and cardiovascular autonomic neuropathy. Diabetes Care. 2004;27(9):2178–83.

    PubMed  CAS  Google Scholar 

  177. 177.

    Singh PP, Mahadi F, Roy A, Sharma P. Reactive oxygen species, reactive nitrogen species and antioxidants in etiopathogenesis of diabetes mellitus type-2. Indian J Clin Biochem. 2009;24(4):324–42.

    PubMed  CAS  Google Scholar 

  178. 178.

    Leibovitz B, Siegel BV. Ascorbic acid, neutrophil function, and the immune response. Int J Vit Nutr Res. 1978;48(2):159–64.

    CAS  Google Scholar 

  179. 179.

    Animashaun A, Kelleher J, Heatley RV, Trejdosiewicz LK, Losowsky MS. The effect of zinc and vitamin C supplementation on the immune status of patients with Crohn’s disease. Clin Nutr. 1990;9(3):137–46.

    PubMed  CAS  Google Scholar 

  180. 180.

    Maggini S, Wintergerst ES, Beveridge S, Hornig DH. Selected vitamins and trace elements support immune function by strengthening epithelial barriers and cellular and humoral immune responses. Br J Nutr. 2007;98(1):S29–35.

    PubMed  CAS  Google Scholar 

  181. 181.

    Feigen GA, Smith BH, Dix CE, Flynn CJ, Peterson NS, Rosenberg LT, et al. Enhancement of antibody production and protection against systemic anaphylaxis by large doses of vitamin C. Res Commun Chem Pathol Pharmacol. 1982;38(2):313–33.

    PubMed  CAS  Google Scholar 

  182. 182.

    Haskell BE, Johnston CS. Complement component C1q activity and ascorbic acid nutriture in guinea pigs. Am J Clin Nutr. 1991;54(6):1228S–30S.

    PubMed  CAS  Google Scholar 

  183. 183.

    Wintergerst ES, Maggini S, Hornig DH. Contribution of selected vitamins and trace elements to immune function. Ann Nutr Metab. 2007;51(4):301–23.

    PubMed  CAS  Google Scholar 

  184. 184.

    Jeong YJ, Hong SW, Kim JH, Jin DH, Kang JS, Lee WJ, et al. Vitamin C-treated murine bone marrow-derived dendritic cells preferentially drive naïve T cells into Th1 cells by increased IL-12 secretions. Cell Immunol. 2011;266(2):192–9.

    PubMed  CAS  Google Scholar 

  185. 185.

    Holmannová D, Koláčková M, Krejsek J. Vitamin C and its physiological role with respect to the components of the immune system. Vnitr Lek. 2012;58(10):743–9.

    PubMed  Google Scholar 

  186. 186.

    Mikirova N, Casciari J, Rogers A, Taylor P. Effect of high-dose intravenous vitamin C on inflammation in cancer patients. J Transl Med. 2012;10:189.

    PubMed  CAS  Google Scholar 

  187. 187.

    Dwivedi S, Goel A, Mandhani A, Natu SM, Khattri S, Pant KK. Diagnostic and prognostic significance of prostate specific antigen and serum interleukin 18 and 10 in patients with locally advanced carcinoma prostate: a prospective comparative study. Asian Pacific J Cancer Prev. 2011;12:1639–44.

    Google Scholar 

  188. 188.

    Dwivedi S, Shukla KK, Gupta G, Sharma P. Non-invasive biomarker in prostate cancer—a novel approach. Ind J Clin Biochem. 2013;28(2):107–9.

    Google Scholar 

  189. 189.

    Khaw KT, Woodhouse P. Interrelation of vitamin C, infection, haemostatic factors and cardiovascular disease. BMJ. 1995;310:1559–63.

    PubMed  CAS  Google Scholar 

  190. 190.

    Ness AR, Powles JW, Khaw KT. Vitamin C and cardiovascular disease—a systematic review. J Cardiovasc Risk. 1997;3:513–21.

    Google Scholar 

  191. 191.

    Woodward M, Lowe GDO, Rumley A, Tunstall-Pedoe H, Philippou H, Lane DA. Epidemiology of coagulation factors, inhibitors and activation markers: the third Glasgow MONICA study (2). Relationships to cardiovascular risk factors and prevalent cardiovascular disease. Br J Haematol. 1997;97:785–97.

    PubMed  CAS  Google Scholar 

  192. 192.

    Woodward M, Rumley A, Tunstall-Pedoe H, Lowe GDO. Association of blood rheology and interleukin-6 with cardiovascular risk factors and prevalent cardiovascular disease. Br J Haematol. 1999;104:246–57.

    PubMed  CAS  Google Scholar 

  193. 193.

    Woodward M, Rumley A, Lowe GDO, Tunstall-Pedoe H. C-reactive protein: associations with haematological variables, cardiovascular risk factors and prevalent cardiovascular disease. Br J Haematol. 2003;122:135–41.

    PubMed  CAS  Google Scholar 

  194. 194.

    Gao X, Bermudez OI, Tucker KL. Plasma C-reactive protein and homocysteine concentrations are related to frequent fruit and vegetable intake in hispanic and non-hispanic white elders. J Nutr. 2004;134:913–8.

    PubMed  CAS  Google Scholar 

  195. 195.

    Ford ES, Liu S, Mannino DM, Giles WH, Smith SJ. C-reactive protein concentration and concentrations of blood vitamins, carotenoids, and selenium among United States adults. Eur J Clin Nutr. 2003;57:1157–63.

    PubMed  CAS  Google Scholar 

  196. 196.

    Lowe GDO. Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease. J Thromb Haemost. 2005;3:1618–27.

    PubMed  CAS  Google Scholar 

  197. 197.

    Wintergerst ES, Maggini S, Hornig DH. Immune-enhancing role of vitamin C and zinc and effect on clinical conditions. Ann Nutr Metab. 2006;50(2):85–94.

    PubMed  CAS  Google Scholar 

  198. 198.

    Stohs SJ, Bagchi D. Mechanisms in the toxicity of metal ions. Free Radic Biol Med. 1995;18(2):321–36.

    PubMed  CAS  Google Scholar 

  199. 199.

    Shaban El-Neweshy M, Said El-Sayed Y. Influence of vitamin C supplementation on lead-induced histopathological alterations in male rats. Exp Toxicol Pathol. 2011;63(3):221–7.

    PubMed  CAS  Google Scholar 

  200. 200.

    Kosik-Bogacka DI, Baranowska-Bosiacka I, Marchlewicz M, Kolasa A, Jakubowska K, Olszewska M, et al. Effect of l-ascorbic acid and/or tocopherol supplementation on electrophysiological parameters of the colon of rats chronically exposed to lead. Med Sci Monit. 2011;17(1):BR16–26.

    PubMed  CAS  Google Scholar 

  201. 201.

    Houston DK, Johnson MA. Does vitamin C intake protect against lead toxicity? Nutr Rev. 2000;58(3):73–5.

    PubMed  CAS  Google Scholar 

  202. 202.

    Singh AL, Singh VK, Srivastava A. Effect of arsenic contaminated drinking water on human chromosome: a case study. 2013. doi: 10.1007/s12291-013-0330-3.

  203. 203.

    Herrera A, Pineda J, Antonio MT. Toxic effects of perinatal arsenic exposure on the brain of developing rats and the beneficial role of natural antioxidants. Environ Toxicol Pharmacol. 2013;36(1):73–9.

    PubMed  CAS  Google Scholar 

  204. 204.

    Antonio Garcia MT, Herrera Dueñas A, Pineda Pampliega J. Hematological effects of arsenic in rats after subchronical exposure during pregnancy and lactation: the protective role of antioxidants. Exp Toxicol Pathol. 2013;65(5):609–14.

    PubMed  CAS  Google Scholar 

  205. 205.

    Singh S, Rana SV. Ascorbic acid improves mitochondrial function in liver of arsenic-treated rat. Toxicol Ind Health. 2010;26(5):265–72.

    PubMed  Google Scholar 

  206. 206.

    Singh MK, Dwivedi S, Yadav SS, Sharma P, Khattri S. Arsenic-induced hepatic toxicity and its attenuation by fruit extract of Emblica officinalis (amla) in mice. Ind J Clin Biochem. 2013. doi:10.1007/s12291-013-0353-9.

  207. 207.

    El-Sokkary GH, Awadalla EA. The protective role of vitamin C against cerebral and pulmonary damage induced by cadmium chloride in male adult albino rat. Open Neuroendocrinol J. 2011;4:1–8.

    CAS  Google Scholar 

  208. 208.

    Hounkpatin ASY, Johnson RC, Guédénon P, Domingo E, Alimba CG, Boko M. Protective effects of vitamin C on haematological parameters in intoxicated Wistar rats with cadmium, mercury and combined cadmium and mercury. Int Res J Biol Sci. 2012;1(8):76–81.

    Google Scholar 

  209. 209.

    Gajawat S, Sancheti G, Goyal PK. Vitamin C against concomitant exposure to heavy metal and radiation: a study on variations in hepatic cellular counts. Asian J Exp Sci. 2005;19(2):53–8.

    CAS  Google Scholar 

  210. 210.

    Lucksch F. C-vitamin und schizophrenic. Wien Klin Wochenschr. 1940;53:1009–11.

    Google Scholar 

  211. 211.

    Subotičanec K, Folnegović-Šmalc V, Korbar M, Meštrović B, Buzina R. Vitamin C status in chronic schizophrenia. Biol Psychiatry. 1990;28(11):959–66.

    PubMed  Google Scholar 

  212. 212.

    Altuntas I, Aksoy H, Coskun I, Caykoylu A, Akcay F. Erythrocyte superoxide dismutase and glutathion peroxidase activities and malondialdehyde and reduced glutathione levels in schizophrenic patients. Clin Chem Lab Med. 2000;38:1277–81.

    PubMed  CAS  Google Scholar 

  213. 213.

    Vaiva G, Thomas P, Leroux JM. Erythrocyte superoxide dismutase determination in positive moments of psychosis. Therapie. 1994;49:343–8.

    PubMed  CAS  Google Scholar 

  214. 214.

    Reddy R, Mahadik SP, Mukherjee M, Murty JN. Enzymes of the antioxidant system in chronic schizophrenic patients. Biol Psychiatry. 1991;30:409–12.

    PubMed  CAS  Google Scholar 

  215. 215.

    Kuloghi M, Ustundag B, Atmaca M, Canatan H, Tezean AE, Cinkiline N. Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell Biochem Funct. 2002;20:171–5.

    Google Scholar 

  216. 216.

    Mahadik SP, Mukherjee S, Correnti I, Sheffer R. Elevated levels of lipid peroxidation products in plasma from drug-naive patients at onset of psychosis. Schizophr Res. 1995;15:66–70.

    Google Scholar 

  217. 217.

    Arvindakshan M, Sitasawad S, Debsikdar V, Ghate M, Evans D, Horrobin DF, et al. Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients. Biol Psychiatry. 2003;53:56–64.

    PubMed  CAS  Google Scholar 

  218. 218.

    Gaur N, Gautam S, Gaur M, Sharma P, Dadheech G, Mishra S. The biochemical womb of schizophrenia: a review. Indian J Clin Biochem. 2008;23(4):307–27.

    PubMed  CAS  Google Scholar 

  219. 219.

    Fridovich I. Superoxide radical: an endogenous toxicant. Annu Rev Pharmacol Toxicol. 1983;23:239–57.

    PubMed  CAS  Google Scholar 

  220. 220.

    Dadheech G, Mishra S, Gautam S, Sharma P. Evaluation of antioxidant deficit in schizophrenia. Indian J Psychiatry. 2008;50(1):16–20.

    PubMed  Google Scholar 

  221. 221.

    Seregi A, Schaefer A, Komlos M. Protective role of brain ascorbic acid content against lipid peroxidation. Experientia. 1978;34:1056–7.

    PubMed  CAS  Google Scholar 

  222. 222.

    Oke AI, May L, Adams RN (1987). Ascorbic acid distribution pattern in human brain. Ann NY Acad Sci. 1987;498:1–12.

    Google Scholar 

  223. 223.

    Arvindakshan M, Ghate M, Ranjekar PK, Evans DR, Mahadik SP. Supplementation with a combination of omega 3 fatty acids and antioxidants (vitamin E and C) improves the outcome of schizophrenia. Schizophr Res. 2003;62:195–204.

    PubMed  Google Scholar 

  224. 224.

    Dadheech G, Mishra S, Gautam S, Sharma P. Oxidative stress—tocopherol, ascorbic acid and reduced glutathione status in schizophrenics. Indian J Clin Biochem. 2006;21(2):34–8.

    PubMed  CAS  Google Scholar 

  225. 225.

    Dakhale GN, Khanzode SD, Khanzode SS, Saoji A. Supplementation of vitamin C with atypical antipsychotics reduces oxidative stress and improves the outcome of schizophrenia. Psychopharmacology. 2005;182:494–8.

    PubMed  CAS  Google Scholar 

  226. 226.

    Gautam M, Agrawal M, Gautam M, Sharma P, Gautam AS, Gautam S. Role of antioxidants in generalised anxiety disorder and depression. Indian J Psychiatry. 2012;54(3):244–7.

    PubMed  Google Scholar 

  227. 227.

    Harrison FE. A critical review of vitamin C for the prevention of age-related cognitive decline and Alzheimer’s disease. J Alzheimers Dis. 2012;29(4):711–26.

    PubMed  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Praveen Sharma.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Chambial, S., Dwivedi, S., Shukla, K.K. et al. Vitamin C in Disease Prevention and Cure: An Overview. Ind J Clin Biochem 28, 314–328 (2013). https://doi.org/10.1007/s12291-013-0375-3

Download citation

Keywords

  • Vitamin C
  • Atherosclerosis
  • Diabetes
  • Immunity
  • Cancer
  • Infertility
  • Heavy metal toxicity